Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Crispr Therapeutics Ag (CRSP)
since 2016 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Crispr Therapeutics Ag.
Table 2 shows the detailed insider transactions.
This company's CIK number is 1674416.
Total stock buying since 2016: $293,942,208.
Total stock sales since 2016: $373,417,799.
Total stock option exercises since 2016: $19,239,965.
Table 3. Detailed insider trading at Crispr Therapeutics Ag (CRSP)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2025-08-18 | Kulkarni Samarth (Chief Executive Officer) | Sale | 13,081 | 58.15 | 760,660 |
2025-08-16 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | .00 | 0 |
2025-08-06 | Treco Douglas A | Buy | 20,000 | 57.03 | 1,140,600 |
2025-07-16 | George Simeon | Buy | 2,969,436 | 52.03 | 154,499,754 |
2025-05-29 | Patel Naimish (Chief Medical Officer) | Sale | 3,932 | 35.94 | 141,316 |
2025-05-28 | Patel Naimish (Chief Medical Officer) | Option Ex | 10,000 | .00 | 0 |
2025-03-21 | Bruno Julianne (Chief Operating Officer) | Sale | 1,714 | 41.23 | 70,668 |
2025-03-21 | Prasad Raju (Chief Financial Officer) | Sale | 2,197 | 41.23 | 90,582 |
2025-03-21 | Kasinger James R. (General Counsel and Secretary) | Sale | 3,185 | 41.23 | 131,317 |
2025-03-21 | Kulkarni Samarth (Chief Executive Officer) | Sale | 10,031 | 41.23 | 413,578 |
2025-03-20 | Bruno Julianne (Chief Operating Officer) | Option Ex | 3,750 | .00 | 0 |
2025-03-20 | Prasad Raju (Chief Financial Officer) | Option Ex | 6,250 | .00 | 0 |
2025-03-20 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 6,250 | .00 | 0 |
2025-03-20 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 19,688 | .00 | 0 |
2025-03-17 | Prasad Raju (Chief Financial Officer) | Sale | 3,762 | 41.80 | 157,251 |
2025-03-14 | Prasad Raju (Chief Financial Officer) | Option Ex | 10,000 | .00 | 0 |
2025-03-12 | Bruno Julianne (Chief Operating Officer) | Sale | 190 | 43.32 | 8,230 |
2025-03-12 | Kasinger James R. (General Counsel and Secretary) | Sale | 1,116 | 43.32 | 48,345 |
2025-03-12 | Kulkarni Samarth (Chief Executive Officer) | Sale | 4,462 | 43.32 | 193,293 |
2025-03-11 | Bruno Julianne (Chief Operating Officer) | Sale | 1,198 | 42.42 | 50,819 |
2025-03-11 | Bruno Julianne (Chief Operating Officer) | Option Ex | 435 | .00 | 0 |
2025-03-11 | Kasinger James R. (General Counsel and Secretary) | Sale | 2,850 | 42.42 | 120,897 |
2025-03-11 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 2,250 | .00 | 0 |
2025-03-11 | Kulkarni Samarth (Chief Executive Officer) | Sale | 9,973 | 42.42 | 423,054 |
2025-03-11 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 9,000 | .00 | 0 |
2025-03-10 | Bruno Julianne (Chief Operating Officer) | Option Ex | 2,399 | .00 | 0 |
2025-03-10 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 5,500 | .00 | 0 |
2025-03-10 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 19,250 | .00 | 0 |
2025-02-26 | Greene John | Buy | 7,000 | 44.85 | 313,950 |
2025-02-19 | Bruno Julianne (Chief Operating Officer) | Sale | 333 | 52.80 | 17,582 |
2025-02-19 | Kasinger James R. (General Counsel and Secretary) | Sale | 1,947 | 52.80 | 102,801 |
2025-02-19 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,288 | 54.00 | 1,379,361 |
2025-02-18 | Bruno Julianne (Chief Operating Officer) | Option Ex | 650 | .00 | 0 |
2025-02-18 | Kasinger James R. (General Counsel and Secretary) | Sale | 9,595 | 53.85 | 516,690 |
2025-02-18 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 3,825 | .00 | 0 |
2025-02-18 | Kulkarni Samarth (Chief Executive Officer) | Sale | 11,640 | 55.05 | 640,782 |
2025-02-18 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 13,250 | .00 | 0 |
2025-02-16 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 20,000 | .00 | 0 |
2024-12-02 | Kulkarni Samarth (Chief Executive Officer) | Sale | 15,000 | 55.10 | 826,560 |
2024-11-11 | Kulkarni Samarth (Chief Executive Officer) | Sale | 30,000 | 55.85 | 1,675,500 |
2024-10-14 | Kasinger James R. (General Counsel and Secretary) | Sale | 1,089 | 46.28 | 50,398 |
2024-10-14 | Kulkarni Samarth (Chief Executive Officer) | Sale | 4,293 | 46.28 | 198,680 |
2024-10-13 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 2,113 | .00 | 0 |
2024-10-13 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 8,333 | .00 | 0 |
2024-06-21 | Bruno Julianne (Chief Operating Officer) | Sale | 3,366 | 56.09 | 188,798 |
2024-06-20 | Bruno Julianne (Chief Operating Officer) | Option Ex | 7,000 | .00 | 0 |
2024-04-15 | Kulkarni Samarth (Chief Executive Officer) | Sale | 19,582 | 60.14 | 1,177,681 |
2024-04-15 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 19,582 | 19.12 | 374,407 |
2024-03-15 | Prasad Raju (Chief Financial Officer) | Sale | 3,524 | 72.69 | 256,159 |
2024-03-15 | Kulkarni Samarth (Chief Executive Officer) | Sale | 20,000 | 72.52 | 1,450,300 |
2024-03-15 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 20,000 | 19.12 | 382,400 |
2024-03-14 | Prasad Raju (Chief Financial Officer) | Option Ex | 10,000 | .00 | 0 |
2024-03-12 | Kasinger James R. (General Counsel and Secretary) | Sale | 1,146 | 74.44 | 85,308 |
2024-03-12 | Kulkarni Samarth (Chief Executive Officer) | Sale | 4,583 | 74.44 | 341,158 |
2024-03-11 | Kasinger James R. (General Counsel and Secretary) | Sale | 2,801 | 78.26 | 219,206 |
2024-03-11 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 2,250 | .00 | 0 |
2024-03-11 | Kulkarni Samarth (Chief Executive Officer) | Sale | 9,802 | 78.26 | 767,104 |
2024-03-11 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 9,000 | .00 | 0 |
2024-03-10 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 5,500 | .00 | 0 |
2024-03-10 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 19,250 | .00 | 0 |
2024-02-20 | Kasinger James R. (General Counsel and Secretary) | Sale | 1,913 | 79.67 | 152,408 |
2024-02-20 | Kulkarni Samarth (Chief Executive Officer) | Sale | 6,370 | 79.67 | 507,497 |
2024-02-18 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 3,825 | .00 | 0 |
2024-02-18 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 13,250 | .00 | 0 |
2024-02-15 | Kulkarni Samarth (Chief Executive Officer) | Sale | 20,000 | 80.88 | 1,617,580 |
2024-02-15 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 20,000 | 19.12 | 382,400 |
2024-01-29 | Kulkarni Samarth (Chief Executive Officer) | Sale | 50,000 | 60.80 | 3,040,050 |
2024-01-29 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 50,000 | 19.12 | 956,000 |
2024-01-16 | Kulkarni Samarth (Chief Executive Officer) | Sale | 20,000 | 62.50 | 1,250,060 |
2024-01-16 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 20,000 | 19.12 | 382,400 |
2023-05-30 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 65.13 | 1,628,350 |
2023-05-30 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 19.12 | 478,000 |
2023-05-23 | Morrow Phuong Khanh (Chief Medical Officer) | Option Ex | 6,938 | .00 | 0 |
2023-04-25 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 50.97 | 1,274,350 |
2023-04-25 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 19.12 | 478,000 |
2023-03-29 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 44.58 | 1,114,475 |
2023-03-29 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 19.12 | 478,000 |
2023-03-11 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 2,250 | .00 | 0 |
2023-03-11 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 9,000 | .00 | 0 |
2023-03-10 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 2,833 | .00 | 0 |
2023-03-10 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 11,833 | .00 | 0 |
2023-02-27 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 48.49 | 1,212,350 |
2023-02-27 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 19.12 | 478,000 |
2023-02-18 | Smith Brendan (Chief Financial Officer) | Option Ex | 3,825 | .00 | 0 |
2023-02-18 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 3,825 | .00 | 0 |
2023-02-18 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 13,250 | .00 | 0 |
2023-01-27 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 51.07 | 1,276,775 |
2023-01-27 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 19.12 | 478,000 |
2022-12-28 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 41.13 | 1,028,350 |
2022-12-28 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 19.12 | 478,000 |
2022-12-06 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 58,233 | 1.81 | 105,401 |
2022-12-03 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 6,667 | .00 | 0 |
2022-12-03 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 40,000 | .00 | 0 |
2022-11-28 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 54.61 | 1,365,275 |
2022-11-28 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 19.12 | 478,000 |
2022-10-14 | Smith Brendan (Chief Financial Officer) | Option Ex | 3,750 | .00 | 0 |
2022-09-28 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 64.77 | 1,619,350 |
2022-09-28 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 16.21 | 405,250 |
2022-08-29 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 66.92 | 1,672,975 |
2022-08-29 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 16.21 | 405,250 |
2022-07-27 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 76.63 | 1,915,850 |
2022-07-27 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 14.39 | 359,750 |
2022-06-29 | Kulkarni Samarth (Chief Executive Officer) | Sale | 25,000 | 61.87 | 1,546,825 |
2022-06-29 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 25,000 | 12.57 | 314,250 |
2022-03-11 | Klein Lawrence Otto (CBO & COO) | Option Ex | 3,000 | .00 | 0 |
2022-03-11 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 2,250 | .00 | 0 |
2022-03-11 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 9,000 | .00 | 0 |
2022-03-10 | Klein Lawrence Otto (CBO & COO) | Option Ex | 4,584 | .00 | 0 |
2022-03-10 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 2,834 | .00 | 0 |
2022-03-10 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 11,834 | .00 | 0 |
2021-12-20 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 17,750 | 1.81 | 32,127 |
2021-12-03 | Klein Lawrence Otto (CBO & COO) | Option Ex | 26,667 | .00 | 0 |
2021-12-03 | Ho Tony W (Executive VP, Head of R&D) | Option Ex | 26,667 | .00 | 0 |
2021-12-03 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 13,333 | .00 | 0 |
2021-12-03 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 80,000 | .00 | 0 |
2021-12-02 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 7,342 | 13.62 | 99,998 |
2021-10-15 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 33,000 | 1.81 | 59,730 |
2021-09-10 | Klein Lawrence Otto (CBO & COO) | Option Ex | 10,000 | .00 | 0 |
2021-09-10 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 10,000 | .00 | 0 |
2021-08-06 | Tomsicek Michael John (Chief Financial Officer) | Sale | 25,000 | 138.84 | 3,471,000 |
2021-08-06 | Tomsicek Michael John (Chief Financial Officer) | Option Ex | 25,000 | 17.75 | 443,750 |
2021-08-05 | Kulkarni Samarth (Chief Executive Officer) | Sale | 28,500 | 128.73 | 3,668,919 |
2021-08-05 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 28,500 | 12.57 | 358,245 |
2021-08-04 | Kulkarni Samarth (Chief Executive Officer) | Sale | 1,500 | 125.02 | 187,530 |
2021-08-04 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 1,500 | 12.57 | 18,855 |
2021-07-19 | Bolzon Bradley J Phd (Director) | Sale | 10,000 | 127.03 | 1,270,340 |
2021-06-30 | Novak Rodger (President) | Sale | 25,000 | 165.00 | 4,125,000 |
2021-06-21 | Novak Rodger (President) | Sale | 25,000 | 128.07 | 3,201,675 |
2021-06-11 | Bolzon Bradley J Phd (Director) | Sale | 10,000 | 127.64 | 1,276,400 |
2021-03-22 | Bolzon Bradley J Phd (Director) | Sale | 30,374 | 132.28 | 4,017,963 |
2021-03-10 | Klein Lawrence Otto (CBO & COO) | Option Ex | 4,583 | .00 | 0 |
2021-03-10 | Ho Tony W (Executive VP, Head of R&D) | Option Ex | 4,583 | .00 | 0 |
2021-03-10 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 2,833 | .00 | 0 |
2021-03-10 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 11,833 | .00 | 0 |
2021-03-10 | Tomsicek Michael John (Chief Financial Officer) | Option Ex | 2,833 | .00 | 0 |
2021-03-05 | Ho Tony W (Executive VP, Head of R&D) | Option Ex | 3,333 | .00 | 0 |
2021-02-19 | Bolzon Bradley J Phd (Director) | Sale | 171,003 | 149.99 | 25,648,568 |
2021-01-19 | Kasinger James R. (General Counsel and Secretary) | Sale | 27,500 | 205.45 | 5,649,820 |
2021-01-19 | Kasinger James R. (General Counsel and Secretary) | Option Ex | 27,500 | 51.49 | 1,415,975 |
2021-01-15 | Klein Lawrence Otto (CBO & COO) | Sale | 25,000 | 215.28 | 5,381,950 |
2021-01-15 | Klein Lawrence Otto (CBO & COO) | Option Ex | 25,010 | 13.50 | 337,635 |
2021-01-15 | Kulkarni Samarth (Chief Executive Officer) | Sale | 20,000 | 214.49 | 4,289,700 |
2021-01-15 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 20,000 | 1.81 | 36,200 |
2020-12-29 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 13,800 | 1.81 | 24,978 |
2020-12-21 | Ho Tony W (Executive VP, Head of R&D) | Sale | 23,551 | 149.69 | 3,525,349 |
2020-12-21 | Ho Tony W (Executive VP, Head of R&D) | Option Ex | 23,551 | 16.90 | 398,011 |
2020-12-16 | Bolzon Bradley J Phd (Director) | Sale | 15,000 | 149.12 | 2,236,785 |
2020-12-10 | Kulkarni Samarth (Chief Executive Officer) | Sale | 20,000 | 142.92 | 2,858,320 |
2020-12-10 | Kulkarni Samarth (Chief Executive Officer) | Option Ex | 20,000 | 1.81 | 36,200 |
2020-12-10 | Bolzon Bradley J Phd (Director) | Sale | 33,000 | 142.54 | 4,703,754 |
Insider trading activities including stock purchases, stock sales, and option exercises
of CRSP listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Crispr Therapeutics Ag (symbol CRSP,
CIK number 1674416) see
the Securities and Exchange Commission (SEC) website.